期刊文献+

高压静电抗溶剂法制备聚乳酸微球 被引量:4

Development of poly (L-lactide) microspheres in high-voltage electrostatic antisolvent process
下载PDF
导出
摘要 以无水乙醇为非溶剂,采用高压静电抗溶剂法制备聚乳酸微球。通过24全因子试验设计对微球粒径和粒径分布的影响因素进行了显著性分析。并考察最显著因素对微球表面形貌的影响规律。结果表明,推进速度是影响微球粒径的最显著因素,最优条件下微球表面光滑、球形度好,粒径分布窄。浓度为3%,相对分子质量为5万~10万的聚乳酸制备的微球,球形度较好。经过高压静电处理后,傅里叶红外光谱测定表明聚乳酸无明显结构摄动;X射线粉末衍射分析表明聚乳酸晶体结构未发生明显变化。 An antisolvent,absolute ethyl alcohol was used in the high-voltage electrostatic antisolvent process to prepare poly(L-lactide) microspheres.A 24 factorial experiment was designed to investigate and identify the relative significance of the processing parameters on particle size and particle size distribution of the products.The results indicated that the effect of push speed was dominant in the results regarding particle size.After optimization,the resulting poly(L-lactide) microspheres exhibited good spherical shape,smooth surface and narrow particle size distribution.When the concentration and molecular weight of poly(L-lactide) were 3%(w/v) and 50~100 kDa respectively,the resulting microspheres showed good spherical shape.Fourier transform infrared(FTIR) spectroscopy measurement found no significant structural perturbation.X-ray powder diffraction(XRPD) analysis revealed no significant crystal structural changes.
出处 《化工进展》 EI CAS CSCD 北大核心 2012年第9期2024-2030,共7页 Chemical Industry and Engineering Progress
基金 国家自然科学基金(51103049 81171471 31170939) 福建省自然科学基金(2010J05027 2011J01223)项目
关键词 高压静电体系 抗溶剂 聚乳酸 因子试验 high-voltage eletrostatic system anti-solvent poly(L-Lactide) factorial experiment
  • 相关文献

参考文献20

  • 1Timko B P, Whitehead K, Gao W, et al. Advances in drug delivery [J]. Annual Review of Materials Research, 2011, 41 ( 1 ): 1-20. 被引量:1
  • 2裘迪,朱宏.聚乳酸类载紫杉醇纳米粒表面修饰的研究进展[J].化工进展,2009,28(7):1198-1201. 被引量:1
  • 3赵杨锋,马利福,黄启谷,杨万泰.活性/可控聚合方法合成生物医用高分子材料研究进展[J].化工进展,2009,28(7):1202-1207. 被引量:5
  • 4刘俊.聚乳酸的合成及应用[J].生物医学工程学杂志,2001,18(2):285-287. 被引量:15
  • 5Xu Y X, Hanna M A. Electrospray encapsulation of water-soluble protein with polylactide: Effects of formulations on morphology, encapsulation efficiency and release profile of particles[J]. International Journal of Pharmaceutics, 2006, 320 (1-2): 30-36. 被引量:1
  • 6Arnold M M, Gorman E M, Schieber L J, et al. NanoCipro encapsulation in monodisperse large porous PLGA microparticles[J]. Journal of Controlled Release, 2007, 121 (1-2): 100-109. 被引量:1
  • 7Wang S B, Chen A Z, Weng L J, et al. Effect of drug-loading methods on drug load, encapsulation efficiency and release properties of alginate/poly-1-arginine/chitosan ternary complex microcapsules[J]. MacromolecularBioscience, 2004, 4 ( 1 ): 27-30. 被引量:1
  • 8Almeria B, Deng W W, Fahmy T M, et al. Controlling the morphology of electrospray-generated PLGA microparticles for drug delivery[J]. Journal of Colloid and Interface Science, 2010,343 ( 1 ): 125-133. 被引量:1
  • 9Hartman R P A, Borral J P, Bnmner D J, et al. The evolution of electrohydrodynamic sprays produced in the cone-jet mode, a physical model[J]. Journal of Electrostatics, 1999, 47 (3): 143-170. 被引量:1
  • 10Kuo S M, Niu G C C, Chang S J, et al. A one-step method for fabricating chitosan mierospheres[J]. Journal of Applied Polymer Science, 2004, 94 (5): 2150-2157. 被引量:1

二级参考文献70

共引文献18

同被引文献82

  • 1Yang Y,Bajaj N,Xu P,et al.Development of highly porous large PLGA microparticles for pulmonary drug delivery[J].Biomaterials,2009,30(10):1947-1953. 被引量:1
  • 2Ungaro F,d'Emmanuele di Villa Bianca R,Giovino C,et al.Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties:In vivo deposition and hypoglycaemic activity after delivery to rat lungs[J].Journal of Controlled Release,2009,135(1):25-34. 被引量:1
  • 3Beck-Broichsitter M,Merkel O M,Kissel T.Controlled pulmonary drug and gene delivery using polymeric nano-carriers[J].Journal of Controlled Release,2012,161(2):214-224. 被引量:1
  • 4Ungaro F,d' Angelo I,Miro A,et al.Engineered PLGA nano-and micro-carriers for pulmonary delivery:Challenges and promises[J].Journal of Pharmacy and Pharmacology,2012,64(9):1217-1235. 被引量:1
  • 5Tsapis N,Bennett D,Jackson B,et al.Trojan particles:Large porous carriers of nanoparticles for drug delivery[J].Proceedings of the National Academy of Sciences of the United States of America,2002,99(19):12001-12005. 被引量:1
  • 6Cai Y P,Chen Y H,Hong X Y,et al.Porous microsphere and its applications[J].International Journal of Nanomedicine,2013,8:1111-1120. 被引量:1
  • 7Edwards D A,Ben-Jebria A,Langer R.Recent advances in pulmonary drug delivery using large,porous inhaled particles[J].Journal of Applied Physiology,1998,85(2):379-385. 被引量:1
  • 8Zhang Y,Yu Y F,Shi X X,et al.Study on the preparation of genipin crosslinked chitosan microspheres of resveratrol and in vitro release[J].Journal of Polymer Research,2013,20(7):175-184. 被引量:1
  • 9Kim M J,Koh Y H.Synthesis of aligned porous poly(ε-caprolactone)(PCL)/hydroxyapatite(HA)composite microspheres[J].Materials Science and Engineering:C,2013,33(4):2266-2272. 被引量:1
  • 10Zou Jianpeng,Ruan Jianming,Zhou Zhongcheng,et al.Preparation of poly(L-lactic acid)microsphere[J].Journal of Macromolecular Science Part B:Physics,2011,50(2):300-305. 被引量:1

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部